From September 16 to 20, 2024, representatives of FDA Laboratory LLC conducted a working visit to Almaty, Republic of Kazakhstan, to participate in a conference dedicated to the development of new business projects and the procedure for registration of biologically active food supplements in the EAEU territory.

During the conference, the laboratory representative, Ellen Lopoyan, delivered a presentation outlining the laboratory’s organizational structure, technical infrastructure, and the procedures and requirements for the registration of biologically active food supplements.

Particular attention from the audience was drawn to the efficient and timely organization of the biologically active food supplements registration process, the laboratory’s technical infrastructure and capabilities, as well as its international accreditation.

During the visit, a number of B2B meetings were also organized with representatives of major companies engaged in the distribution of biologically active food supplements. Opportunities for cooperation and areas of mutual collaboration were discussed, which are important for the development of a unified market within the region.
Such working visits create broad opportunities for the laboratory and represent an important step not only in its further development but also in enhancing quality across the entire market and establishing new standards.